Succinyl-CoA-based energy metabolism dysfunction in chronic heart failure.

Area of Science:

• Biochemistry
• Cardiology
• Mitochondrial Biology

Background:

• Heart failure (HF) is a major cause of mortality and hospitalizations.
• Cardiac mitochondrial dysfunction is implicated in HF, but mechanisms are unclear.
• Succinyl-CoA metabolism is a potential area of investigation.

Purpose of the Study:

• To investigate the metabolic basis of mitochondrial dysfunction in chronic heart failure.
• To identify the role of succinyl-CoA in cardiac mitochondrial dysfunction.
• To explore potential therapeutic interventions targeting succinyl-CoA metabolism.

Main Methods:

• Induction of myocardial infarction (MI) in a mouse model.
• Analysis of myocardial succinyl-CoA levels and oxidative phosphorylation (OXPHOS) capacity.
• Measurement of enzyme activity and protein levels involved in succinyl-CoA metabolism.
• Intervention with 5-aminolevulinic acid (5-ALA).

Main Results:

• MI mice exhibited decreased myocardial succinyl-CoA levels, impairing OXPHOS capacity.
• Increased heme synthesis and ketolysis, with altered enzyme expression, were observed in MI mice.
• 5-ALA administration restored succinyl-CoA levels, improved OXPHOS, and prevented HF progression.

Conclusions:

• Altered succinyl-CoA metabolism is characteristic of chronic heart failure.
• Reduced succinyl-CoA levels contribute to mitochondrial dysfunction and HF progression.
• Nutritional interventions targeting succinyl-CoA metabolism may offer promising therapeutic strategies for HF.